16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)

      review-article
      , *
      Biomolecules
      MDPI
      mucin, cancer, O-glycosylation, MUC1, MUC4, MUC16, signaling

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glycosylation is one of the most abundant post-translational modifications that occur within the cell. Under normal physiological conditions, O-linked glycosylation of extracellular proteins is critical for both structure and function. During the progression of cancer, however, the expression of aberrant and truncated glycans is commonly observed. Mucins are high molecular weight glycoproteins that contain numerous sites of O-glycosylation within their extracellular domains. Transmembrane mucins also play a functional role in monitoring the surrounding microenvironment and transducing these signals into the cell. In cancer, these mucins often take on an oncogenic role and promote a number of pro-tumorigenic effects, including pro-survival, migratory, and invasive behaviors. Within this review, we highlight both the processes involved in the expression of aberrant glycan structures on mucins, as well as the potential downstream impacts on cellular signaling.

          Related collections

          Most cited references138

          • Record: found
          • Abstract: found
          • Article: not found

          Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

          Despite the success of tyrosine kinase-based cancer therapeutics, for most solid tumors the tyrosine kinases that drive disease remain unknown, limiting our ability to identify drug targets and predict response. Here we present the first large-scale survey of tyrosine kinase activity in lung cancer. Using a phosphoproteomic approach, we characterize tyrosine kinase signaling across 41 non-small cell lung cancer (NSCLC) cell lines and over 150 NSCLC tumors. Profiles of phosphotyrosine signaling are generated and analyzed to identify known oncogenic kinases such as EGFR and c-Met as well as novel ALK and ROS fusion proteins. Other activated tyrosine kinases such as PDGFRalpha and DDR1 not previously implicated in the genesis of NSCLC are also identified. By focusing on activated cell circuitry, the approach outlined here provides insight into cancer biology not available at the chromosomal and transcriptional levels and can be applied broadly across all human cancers.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Mucins in cancer: protection and control of the cell surface.

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A renaissance for SRC.

                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Biomolecules
                Biomolecules
                biomolecules
                Biomolecules
                MDPI
                2218-273X
                30 July 2016
                September 2016
                : 6
                : 3
                : 34
                Affiliations
                Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA; ryan.hanson@ 123456unmc.edu
                Author notes
                [* ]Correspondence: mahollin@ 123456unmc.edu ; Tel.: +1-402-559-8343
                Article
                biomolecules-06-00034
                10.3390/biom6030034
                5039420
                27483328
                2f7d0030-209a-4851-bf42-eaba006a00f4
                © 2016 by the authors; licensee MDPI, Basel, Switzerland.

                This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 03 June 2016
                : 21 July 2016
                Categories
                Review

                mucin,cancer,o-glycosylation,muc1,muc4,muc16,signaling
                mucin, cancer, o-glycosylation, muc1, muc4, muc16, signaling

                Comments

                Comment on this article